Allied Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	817.85	789.08	978.33	618.49	679.75	757.39
Short-Term Investments	34.53	64.83	8.91	106.28	113.25	386.82
Cash & Short-Term Investments	852.38	853.91	987.24	724.77	793	1,144
Cash Growth	-20.81%	-13.51%	36.21%	-8.60%	-30.69%	19.27%
Accounts Receivable	159.06	137.95	131.24	109.85	118.54	105.08
Other Receivables	4.35	1.53	1.75	3.6	5.39	4.63
Receivables	163.42	139.48	132.99	113.46	123.92	109.71
Inventory	507.98	511.41	527.54	601.48	596.47	508.09
Other Current Assets	20.53	16.68	15.33	17.17	21.54	23.52
Total Current Assets	1,544	1,521	1,663	1,457	1,535	1,786
Property, Plant & Equipment	540.83	540.7	567.87	594	623.49	625.99
Long-Term Investments	6.43	-	-	0.05	0.73	2.59
Long-Term Deferred Tax Assets	38.23	21.57	16.67	17.37	12.55	15.44
Other Long-Term Assets	51.64	8.05	9.22	10.62	11.31	11.84
Total Assets	2,181	2,092	2,257	2,079	2,183	2,441
Accounts Payable	43.72	31.1	26.66	27.65	38.64	47.21
Accrued Expenses	-	49.8	47.94	35.5	43.78	30.61
Short-Term Debt	670	670	870	700	720	1,110
Current Portion of Long-Term Debt	18.31	18.31	18.31	18.31	18.31	125.99
Current Portion of Leases	4.83	5.05	5.36	5.1	5.49	5.79
Current Income Taxes Payable	50.8	15.12	10.88	16.85	27.46	1.64
Current Unearned Revenue	7.97	1.69	2.6	4.64	1.26	1.59
Other Current Liabilities	67.86	8.98	14.5	20.65	39.84	23.91
Total Current Liabilities	863.47	800.04	996.25	828.69	894.77	1,347
Long-Term Debt	29.88	34.46	52.76	71.07	89.38	-
Long-Term Leases	2.97	4.1	7.74	0.95	3.89	1.03
Pension & Post-Retirement Benefits	-	8.95	-	5.92	3.94	9.64
Long-Term Deferred Tax Liabilities	2.42	9.64	4.57	3.49	7.43	2.47
Other Long-Term Liabilities	8.59	-	-	-	-	-
Total Liabilities	907.34	857.19	1,061	910.12	999.4	1,360
Common Stock	962.43	962.43	960.24	957.85	953.85	953.51
Additional Paid-In Capital	12.76	12.13	9.65	7.74	5.67	5.19
Retained Earnings	302.48	263.95	231.31	209.28	229.88	127.6
Comprehensive Income & Other	-3.56	-3.9	-5.67	-6.08	-5.79	-4.79
Shareholders' Equity	1,274	1,235	1,196	1,169	1,184	1,082
Total Liabilities & Equity	2,181	2,092	2,257	2,079	2,183	2,441
Total Debt	725.99	731.91	954.17	795.43	837.07	1,243
Net Cash (Debt)	126.4	122	33.07	-70.66	-44.06	-98.6
Net Cash Growth	-1.37%	268.93%	-	-	-	-
Net Cash Per Share	1.31	1.27	0.34	-0.74	-0.46	-1.03
Filing Date Shares Outstanding	96.34	96.24	96.02	95.78	95.38	95.35
Total Common Shares Outstanding	96.34	96.24	96.02	95.78	95.38	95.35
Working Capital	680.84	721.44	666.85	628.19	640.17	438.79
Book Value Per Share	13.23	12.83	12.45	12.20	12.41	11.34
Tangible Book Value	1,274	1,235	1,196	1,169	1,184	1,082
Tangible Book Value Per Share	13.23	12.83	12.45	12.20	12.41	11.34
Land	-	210.22	210.22	210.22	210.22	210.22
Buildings	-	290.85	288.9	286.98	258.26	263.3
Machinery	-	981.77	965.22	950.97	915.59	858.72
Construction In Progress	-	14.98	6.07	6.96	42.43	56.22